Distribution of sigma receptors in EMT-6 cells: Preliminary biological evaluation of PB167 and potential for in-vivo PET

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 11, 2005, Pages 1453-1459

  Colabufo, Nicola Antonio ^a   Berardi, Francesco ^a   Contino, Marialessandra ^a   Fazio, Ferruccio ^b   Matarrese, Mario ^b   Moresco, Rosa Maria ^b   Niso, Mauro ^a   Perrone, Roberto ^a   Tortorella, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PB 167; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG; CYCLOHEXANE DERIVATIVE; DIAGNOSTIC AGENT; PB167; PIPERAZINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; SIGMA-1 RECEPTOR; SIGMA-2 RECEPTOR; TRITIUM;

ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CHEMICAL STRUCTURE; IN VIVO STUDY; KINETICS; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RECEPTOR AFFINITY; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; BINDING COMPETITION; CELL MEMBRANE; CELL SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; TUMOR CELL LINE;

ANIMALS; BINDING, COMPETITIVE; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CYCLOHEXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGANDS; MICE; PIPERAZINES; RADIOPHARMACEUTICALS; RECEPTORS, SIGMA; TOMOGRAPHY, EMISSION-COMPUTED; TRITIUM;

EID: 34548081983     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.57.11.0011     Document Type: Article

References (28)

1. 18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography. Br. J. Cancer 90: 2232-2242
2. 2 activity. J. Med. Chem. 47: 2308-2317
3. 2 receptor subtypes. Neuroscience 76: 467-477
4. Caveliers, V., Everaert, H., Lahoutte, T., Dierickx, L. O., John, C. S., Bossuyt, A. (2001) Labeled sigma receptor ligands: can their role in neurology and oncology be extended? Eur. J. Nucl. Med. 28: 133-135
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108
6. 4 receptor density in rat striatum using PB12 as a probe. Eur. J. Pharmacol. 427: 1-5
7. 2 ligand activity in the isolated guinea-pig bladder. Naunyn Schmiedeberg's Arch. Pharmacol. 368: 106-112
8. 1 antagonists in tumour cell lines. Naunyn Schmiedeberg's Arch. Pharmacol. 370: 106-113
9. Crawford, K. W., Bowen, W. D (2002) Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res. 62: 313-322
10. Dearling, J. L., Lewis, J. S., Mullen, G. E., Welch, M. J., Blower, P. J. (2002) Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships. J. Biol. Inorg. Chem. 7: 249-259
11. 18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor. Synapse 43: 259-267
12. John, C. S., Vilner, B. J., Schwartz, A. M., Bowen, W. D. (1996) Characterization of sigma receptor binding sites in human biopsied solid breast tumor. J. Nucl. Med. 37: 267P
13. 125I]BP: a potential sigma receptor marker for human prostate tumors. Nucl. Med. Biol. 25: 189-194
14. John, C. S., Vilner, B. J., Geyer, B. C., Moody, T., Bowen, W. D. (1999) Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumor. Cancer Res. 59: 4578-4583
15. 1 receptors. Nucl. Med. Biol. 27: 255-261
16. 11C]SA4503, by P-glycoprotein modulation. Synapse 48: 80-86
17. 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3- phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies. Nucl Med. Biol. 30: 273-284
18. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 239-248
19. Mach, R. H., Smith, C. R., Al-Nabusi, I., Whirrett, B. R., Childers, S. R., Wheeler, K. T. (1997) Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res. 57: 156-161
20. 125I] IUDR. Nucl. Med. Biol. 28: 451-458
21. Matsumoto, R. R., Bowen, W. D., Tom, M. A., Van Nhi, V., Truong, D. D., De Costa, B. (1995) Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur. J. Pharmacol. 280: 301-310
22. Mossman, T. (1983) Rapid colorimetric assay for cellular growth and survival. J. Immunol. Methods 65: 55-63
23. Rowland, D. J., Tu, Z., Mach, R. H., Welch, M. J. (2003) Investigation of a new sigma 2 receptor ligand for detection of breast cancer. J. Label. Compd. Radiopharm. 46: S1-S403
24. Spruce, B. A., Campbell, L. A., McTavish, N., Cooper, M. A., Appleyard, M. V. L., O'Neill, M., Howie, J., Samson, J., Watt, S., Murray, K., McLean, D., Leslie, N. R., Safrany, S. T., Ferguson, M. J., Peters, J. A., Prescott, A. R., Box, G., Hayes, A., Nutley, B., Raynaud, F., Downes, C. P., Lambert, J. J., Thompson, A. M., Eccles, S. (2004) Small molecule antagonists of the σ-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res. 54: 4875-4886
25. 11C-SA4503: a feasibility study. J. Nucl. Med. 45: 1939-1945
26. Vilner, B. J., Bowen, W. D. (2000) Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. J. Pharmacol. Exp. Ther. 292: 900-911
27. Vilner, B. J., John, C. S., Bowen, W. D. (1995) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 55: 408-413
28. Wheeler, K. T., Wang, L. M., Wallen, C. A., Childers, S. R., Cline, J. M., Keng, P. C., Mach, R. H. (2000) Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br. J. Cancer 82: 1223-1232